Start free trial

Latest Asarina Pharma News & Updates

See the latest news and media coverage for Asarina Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Asarina Pharma

Swedish biotechnology company in liquidation

asarinapharma.com
Headquarters
Haga, Sweden
Founded year
2006
Company type
Private company
Number of employees
2–10
Industry
Pharmaceuticals

Last updated

Latest news about Asarina Pharma

In short: Asarina Pharma sold Sepranolone assets to Relmada and applied to delist amid voluntary liquidation

Company announcements

Asarina Pharma

Asarina Pharma applies for delisting of shares

Following a decision for voluntary liquidation on August 21, 2024, the board applies for delisting from Nasdaq First North Growth Market. Trading end date to be announced separately.

Asarina Pharma

Asarina Pharma announces partnering failure and proposes liquidation

The company discontinues Sepranolone partnering efforts, reports equity below half of share capital per control balance sheet, and plans an extraordinary general meeting on 21 August 2024 for orderly liquidation.

Unlock all announcements with a

Media coverage

Dagens industri

Asarina Pharma reduced the loss

Asarina Pharma reports for the third quarter of the year an operating result of -8.1 million kronor (-17.5) and an earnings per share of -0:40 kronor (-0:90). The past...

Life Sciences Sweden

Receives funding for study on severe PMS

The biotech company Asarina Pharma (formerly Umecrine Mood) announces today Wednesday that the company has raised new capital to conduct a phase IIb study with its drug candidate...

Unlock all articles with a

Never miss news about Asarina Pharma

Track Asarina Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.